These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29330172)

  • 21. The intractable cigarette 'filter problem'.
    Harris B
    Tob Control; 2011 May; 20 Suppl 1(Suppl_1):i10-6. PubMed ID: 21504917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local Nordic tobacco interests collaborated with multinational companies to maintain a united front and undermine tobacco control policies.
    Hiilamo H; Glantz SA
    Tob Control; 2013 Mar; 22(2):154-64. PubMed ID: 22199013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tobacco industry and public health responses to state and local efforts to end tobacco sales from 1969-2020.
    McDaniel PA; Malone RE
    PLoS One; 2020; 15(5):e0233417. PubMed ID: 32442202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nicotine delivery device without the nicotine? Tobacco industry development of low nicotine cigarettes.
    Dunsby J; Bero L
    Tob Control; 2004 Dec; 13(4):362-9. PubMed ID: 15564619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scientific analysis of second-hand smoke by the tobacco industry, 1929-1972.
    Schick S; Glantz S
    Nicotine Tob Res; 2005 Aug; 7(4):591-612. PubMed ID: 16085530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of reduced-risk nicotine-delivery products on smoking prevalence and cigarette sales: an observational study.
    Pesola F; Phillips-Waller A; Beard E; Shahab L; Sweanor D; Jarvis M; Hajek P
    Public Health Res (Southampt); 2023 Sep; 11(7):1-39. PubMed ID: 37795840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Philip Morris research on precursors to the modern e-cigarette since 1990.
    Dutra LM; Grana R; Glantz SA
    Tob Control; 2017 Dec; 26(e2):e97-e105. PubMed ID: 27852893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Destroyed documents: uncovering the science that Imperial Tobacco Canada sought to conceal.
    Hammond D; Chaiton M; Lee A; Collishaw N
    CMAJ; 2009 Nov; 181(10):691-8. PubMed ID: 19828670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence, Policy, and E-Cigarettes--Will England Reframe the Debate?
    Green SH; Bayer R; Fairchild AL
    N Engl J Med; 2016 Apr; 374(14):1301-3. PubMed ID: 27050203
    [No Abstract]   [Full Text] [Related]  

  • 31. "Working the system"--British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents.
    Smith KE; Fooks G; Collin J; Weishaar H; Mandal S; Gilmore AB
    PLoS Med; 2010 Jan; 7(1):e1000202. PubMed ID: 20084098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cigarette controversy.
    Cummings KM; Brown A; O'Connor R
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1070-6. PubMed ID: 17548665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community tobacco control leaders' perceptions of harm reduction.
    Joseph AM; Hennrikus D; Thoele MJ; Krueger R; Hatsukami D
    Tob Control; 2004 Jun; 13(2):108-13. PubMed ID: 15175521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Financial Conflicts of Interest and Stance on Tobacco Harm Reduction: A Systematic Review.
    Hendlin YH; Vora M; Elias J; Ling PM
    Am J Public Health; 2019 Jul; 109(7):e1-e8. PubMed ID: 31095414
    [No Abstract]   [Full Text] [Related]  

  • 35. Tobacco, nicotine and harm reduction.
    Le Houezec J; McNeill A; Britton J
    Drug Alcohol Rev; 2011 Mar; 30(2):119-23. PubMed ID: 21375611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secret science: tobacco industry research on smoking behaviour and cigarette toxicity.
    Hammond D; Collishaw NE; Callard C
    Lancet; 2006 Mar; 367(9512):781-7. PubMed ID: 16517278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marketing 'less harmful, low-tar' cigarettes is a key strategy of the industry to counter tobacco control in China.
    Yang G
    Tob Control; 2014 Mar; 23(2):167-72. PubMed ID: 23349230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The tobacco reliquary.
    Blum A
    CMAJ; 2015 Feb; 187(2):133-4. PubMed ID: 25452317
    [No Abstract]   [Full Text] [Related]  

  • 39. Current status of tobacco policy and control.
    Paoletti L; Jardin B; Carpenter MJ; Cummings KM; Silvestri GA
    J Thorac Imaging; 2012 Jul; 27(4):213-9. PubMed ID: 22847588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential reduced exposure products (PREPs) in industry trial testimony.
    Wayne GF
    Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv90-7. PubMed ID: 17130630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.